China's central bank on Monday rolled over maturing medium-term loans while keeping borrowing costs unchanged for the fourth straight month. ( read original story ...)
Alibaba’s Ant Group Starts Filing Process For Blockbuster China IPO
Alibaba’s fintech arm Ant Group has started the process to dual list in Shanghai and Hong Kong.The group, China’s biggest mobile payments company, has now made a preparatory filing with China’s ... ( read original story ...)
China greenlights two sci-tech innovation IPOs
China's securities regulator has approved the registration for the initial public offerings (IPOs) of two companies on the science and technology innovation board. Foxit Software Incorporated and ... ( read original story ...)
China’s Banking Watchdog Warns Fed Easing Risks Financial Crisis
The Federal Reserve’s unparalleled stimulus risks plunging the world into financial crisis, according to the chairman of China’s banking watchdog, who also warned that bad debts at Chinese financial ... ( read original story ...)
Every major Asian market has a Nasdaq-wannabe. Can Hong Kong or Shanghai tech boards close the gap?
The Nasdaq has many advantages over the tech boards in Hong Kong, Shanghai, Tokyo and Seoul. These advantages include America’s appeal to global investors and the Silicon Valley network. ( read original story ...)
China approves 6 new IPO applications
China's top securities regulator has approved the initial public offering (IPO) applications of six companies. Shanghai Huafon Aluminium Corporation, Hangzhou Haoyue Industrial Co Ltd, Shanghai ... ( read original story ...)
Covid-19 vaccine hopefuls surge in stock market debuts
CureVac raised $245m in an initial public offering on Nasdaq to accelerate the development of its Covid-19 vaccine. The sale priced at the top of the range, at $16 per share, and the stock was around ... ( read original story ...)